Defining the role of TCAB1 and its phase separation in telomerase assembly.
定义 TCAB1 的作用及其在端粒酶组装中的相分离。
基本信息
- 批准号:10670264
- 负责人:
- 金额:$ 30.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectApoptosisAutomobile DrivingBiochemicalBiologicalCell NucleolusCell physiologyCellsChargeChromosomesComplexCritical PathwaysDNADNA SequenceDefectDevelopmentDiseaseDyskeratosis CongenitaExclusionGoalsHomeostasisHumanHuman ChromosomesHuman bodyIn VitroInterdisciplinary StudyLabelLaboratoriesLeadLiquid substanceMalignant NeoplasmsMethodsModelingMolecularN-terminalNuclearNucleic AcidsOrganellesPatientsPeptidesPhasePhysical condensationPhysiologicalPremature aging syndromeProliferatingPropertyProteinsRNA FoldingRNA-Binding ProteinsRNA-Directed DNA PolymeraseRegulationRibonucleoproteinsRoleTelomeraseTelomerase RNA ComponentTelomerase inhibitionTelomere MaintenanceTelomere ShorteningTestingTherapeuticTimeTissuesTranscriptaseWD RepeatWorkcancer cellcancer therapychromosome replicationcofactordriving forceexperimental studymolecular imagingnovel strategiesprematurerecruitsingle moleculestem cell populationstem cell proliferationstem cellstargeted treatmenttelomeretherapy developmenttooltraffickingtumor
项目摘要
PROJECT SUMMARY/ABSTRACT
Telomeres, the ends of human chromosomes, shorten every time a cell divides. When telomeres become too
short, human cells stop dividing or undergo programmed cell death. Telomerase adds telomeric DNA onto
chromosome ends to counteract telomere shortening. In the human body telomerase is expressed in stem cells,
allowing them to continuously proliferate throughout our lives. Defects in telomerase function lead to premature
aging diseases such as Dyskeratosis Congenita, which are caused by the depletion of stem cell populations. In
addition, telomerase is expressed in ~90% of tumors and allows cancer cells to proliferate indefinitely. It is
therefore critical to develop targeted approaches to promote or interfere with telomerase activity to treat
premature aging diseases and cancer, respectively. Telomerase is a complex ribonucleoprotein that contains
the telomerase reverse transcriptase protein (TERT), the telomerase RNA (TR), and various co-factors including
the telomerase cajal body protein 1 (TCAB1). TCAB1 is required for telomerase function in human cells but the
mechanism underlying its contribution to telomere maintenance is controversial. Initially it was suggested that
telomerase is properly assembled and fully active in the absence of TCAB1, leading to the model that TCAB1 is
required for telomerase trafficking to telomeres. More recent observations suggest that TCAB1 is required for
telomerase catalytic activity by promoting TR folding without affecting overall RNP assembly. Importantly, all
previous studies clearly demonstrate that TR is enriched in nucleoli in cells lacking TCAB1. Our prior work has
shown that TERT is specifically excluded from nucleoli. We therefore believe that in the absence of TCAB1,
telomerase fails to assemble because TR is trapped in nucleoli and TERT is excluded from nucleoli. Both nucleoli
and Cajal bodies are phase separated nuclear organelles. Phase separation is an emerging molecular
phenomenon by which proteins and nucleic acids from liquid like droplets. In preliminary experiments we have
shown that TCAB1 contains disordered regions that can undergo liquid-liquid phase separation. Our central
hypothesis is that the specific phase separation properties of TCAB1 facilitate telomerase assembly by driving
the exclusion of the telomerase RNA from nucleoli and promoting its interaction with Cajal bodies. To test this
hypothesis, we will address the following specific aims, (1) Determine the role of TCAB1 in telomerase assembly,
and (2) Define the phase separation properties of TCAB1 and dissect their contribution to telomerase assembly.
项目总结/摘要
端粒,人类染色体的末端,在细胞每次分裂时都会缩短。当端粒变得太
简而言之,人类细胞停止分裂或经历程序性细胞死亡。端粒酶将端粒DNA添加到
染色体末端以抵消端粒缩短。在人体中,端粒酶在干细胞中表达,
让它们在我们的生活中不断增殖。端粒酶功能缺陷导致过早的
衰老性疾病,如先天性角化不良,这是由干细胞群的耗竭引起的。在
此外,端粒酶在约90%的肿瘤中表达,并允许癌细胞无限增殖。是
因此,开发靶向方法来促进或干扰端粒酶活性以治疗
早老疾病和癌症。端粒酶是一种复杂的核糖核蛋白,
端粒酶逆转录酶蛋白(TERT)、端粒酶RNA(TR)和各种辅因子,包括
端粒酶卡哈尔体蛋白1(TCAB 1)。TCAB 1是人类细胞中端粒酶功能所必需的,
其对端粒维持的作用机制仍有争议。最初有人提出,
端粒酶在缺乏TCAB 1的情况下被正确组装并完全活化,导致TCAB 1被激活的模型。
端粒酶运输到端粒所必需的。最近的观察表明,TCAB 1是必需的,
端粒酶催化活性,促进TR折叠,而不影响整体RNP组装。重要的是所有
以前的研究清楚地表明TR在缺乏TCAB 1的细胞中富集在核仁中。我们之前的工作
表明TERT被特异性地排除在核仁之外。因此,我们认为,在没有TCAB 1的情况下,
端粒酶不能组装,因为TR被捕获在核仁中,而TERT被排除在核仁之外。两个核仁
和Cajal小体是相分离的核细胞器。相分离是一种新兴的分子
蛋白质和核酸从液滴中分离出来的现象。在初步实验中,
表明TCAB 1含有可以进行液-液相分离的无序区域。我们的中央
假设TCAB 1的特异性相分离特性通过驱动端粒酶组装来促进端粒酶组装
将端粒酶RNA从核仁中排除,促进其与Cajal小体的相互作用。为了验证这一
假设,我们将致力于以下具体目标,(1)确定TCAB 1在端粒酶组装中的作用,
(2)确定TCAB 1的相分离特性并分析其在端粒酶组装中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jens Christopher Schmidt其他文献
Jens Christopher Schmidt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jens Christopher Schmidt', 18)}}的其他基金
Defining the role of TCAB1 and its phase separation in telomerase assembly.
定义 TCAB1 的作用及其在端粒酶组装中的相分离。
- 批准号:
10796472 - 财政年份:2021
- 资助金额:
$ 30.63万 - 项目类别:
Defining the role of TCAB1 and its phase separation in telomerase assembly.
定义 TCAB1 的作用及其在端粒酶组装中的相分离。
- 批准号:
10178904 - 财政年份:2021
- 资助金额:
$ 30.63万 - 项目类别:
Defining the role of TCAB1 and its phase separation in telomerase assembly.
定义 TCAB1 的作用及其在端粒酶组装中的相分离。
- 批准号:
10474274 - 财政年份:2021
- 资助金额:
$ 30.63万 - 项目类别:
Molecular Mechanisms of Telomerase Catalysis and its Recruitment to Telomeres
端粒酶催化及其向端粒募集的分子机制
- 批准号:
9898387 - 财政年份:2016
- 资助金额:
$ 30.63万 - 项目类别:
Analysis of the Molecular Mechanisms of Telomerase Recruitment to Telomeres and Telomerase Catalysis
端粒酶招募端粒及端粒酶催化的分子机制分析
- 批准号:
9331708 - 财政年份:2016
- 资助金额:
$ 30.63万 - 项目类别:
Analysis of the Molecular Mechanisms of Telomerase Recruitment to Telomeres and Telomerase Catalysis
端粒酶招募端粒及端粒酶催化的分子机制分析
- 批准号:
9162424 - 财政年份:2016
- 资助金额:
$ 30.63万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 30.63万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 30.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 30.63万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 30.63万 - 项目类别:
Discovery Grants Program - Individual